Closed 16 of 133 events
Threads / Human Medicines Regulations Amendments / Timeline
Lifecycle stage Response Published
113 days in stage

Human Medicines Regulations Amendments

The Department of Health and Social Care and MHRA are amending the Human Medicines Regulations through draft regulations and consultation on changes to health service product information disclosure rules, aimed at benefiting NHS patients and British businesses through modernised medicines access procedures. The amendments represent significant changes to the regulatory framework governing medicines approval and provision.

Log in for AI briefing
Showing 16 of 133 signals
Sort Latest first Oldest first
Family 1
Signal
Year
Body
Role
Clear all
Family: Scrutiny and evidence
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, if he will publish any of the pre-clinical data, study reports or assessments made by the Medicines and Healthcare products Regulatory Agency

To ask the Secretary of State for Health and Social Care, if he will publish any of the pre-clinical data, study reports or assessments made by the Medicines and Healthcare products Regulatory Agency (MHRA) that the MHRA’s Chief Safety Officer …

▤ View document · ↗ GOV.UK
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his Department's policies of the increasing percentage of funding for the World

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his Department's policies of the increasing percentage of funding for the World Health Organization coming from (a) specified and …

▤ View document · ↗ GOV.UK
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, if he will publish the most recent Medicines and Healthcare products Regulatory Agency (MHRA) pharmacovigilance assessment or signal evaluatio

To ask the Secretary of State for Health and Social Care, if he will publish the most recent Medicines and Healthcare products Regulatory Agency (MHRA) pharmacovigilance assessment or signal evaluation report that specifically addresses potential cancer/n

▤ View document · ↗ GOV.UK
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, whether external organisations, including charities and patient organisations, will have opportunities to submit written evidence to any revie

To ask the Secretary of State for Health and Social Care, whether external organisations, including charities and patient organisations, will have opportunities to submit written evidence to any review of meningococcal group B vaccines or meningococcal gr

▤ View document · ↗ GOV.UK
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, that the recognition of air ambulance services within NHS emergency services fuel access arrangements is safeguarded and maintained, ensuring

To ask the Secretary of State for Health and Social Care, that the recognition of air ambulance services within NHS emergency services fuel access arrangements is safeguarded and maintained, ensuring priority access in line with other frontline emergency

▤ View document · ↗ GOV.UK
29 Apr 2026 | Written question Department of Health and Social Care linked

To ask His Majesty's Government what steps they are taking to secure supplies of medicines, medical devices and medical consumables in the case of war or pandemic; and whether those steps include buil

To ask His Majesty's Government what steps they are taking to secure supplies of medicines, medical devices and medical consumables in the case of war or pandemic; and whether those steps include building and maintaining strategic reserves of those suppli

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Chief Executive of the NHS Business Services Authority on the operation of the Vaccine Damage Paym

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Chief Executive of the NHS Business Services Authority on the operation of the Vaccine Damage Payment Scheme.

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines ac

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the US CLOUD Act on the security of NHS patient data held or processed by US-based comp

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the US CLOUD Act on the security of NHS patient data held or processed by US-based companies; and whether …

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines ac

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, what information his Department holds on where licenced donor animal blood is sourced from to develop animal blood-enriched agar for use acros

To ask the Secretary of State for Health and Social Care, what information his Department holds on where licenced donor animal blood is sourced from to develop animal blood-enriched agar for use across the NHS; and if he will make …

▤ View document · ↗ GOV.UK
28 Apr 2026 | Written question Department of Health and Social Care linked

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines ac

To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub

▤ View document · ↗ GOV.UK
2 Dec 2024 | Written question Department of Health and Social Care linked

Analgesics

To ask the Secretary of State for Health and Social Care, what his policy is on (a) doctors and (b) other qualified medical personnel administering pain-relieving drugs which may shorten lives; and whether regulations on that issue changed after the …

▤ View document · ↗ GOV.UK · ↓
26 Nov 2024 | Written question Department of Health and Social Care linked

Tranexamic Acid

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making Tranexamic Acid (TXA) a Schedule 19 Drug. Answer: Discussions on the administration of tranexamic acid (TXA) formed part …

▤ View document · ↗ GOV.UK · ↓